Cargando…

Changes of clinical symptoms in patients with new psychoactive substance (NPS)‐related disorders from fiscal year 2012 to 2014: A study in hospitals specializing in the treatment of addiction

AIMS: The use of new psychoactive substances (NPS) has become increasingly widespread over the last decade, in Japan and internationally. NPS are associated with a range of increasingly serious clinical, public, and social issues. Political measures to ameliorate the effects of NPS in Japan have foc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Funada, Daisuke, Matsumoto, Toshihiko, Tanibuchi, Yuko, Kawasoe, Yasunari, Sakakibara, Satoru, Naruse, Nobuya, Ikeda, Shunichiro, Sunami, Takashi, Muto, Takeo, Cho, Tetsuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292321/ https://www.ncbi.nlm.nih.gov/pubmed/30968601 http://dx.doi.org/10.1002/npr2.12053

Ejemplares similares

The influence of tightening regulations on patients with new psychoactive substance‐related disorders in Japan
por: Tanibuchi, Yuko, et al.
Publicado: (2018)

The Dynamic Environment of Crypto Markets: The Lifespan of New Psychoactive Substances (NPS) and Vendors Selling NPS
por: Wadsworth, Elle, et al.
Publicado: (2018)

Novel Psychoactive Substances and Behavioral Addictions
por: Martinotti, Giovanni, et al.
Publicado: (2014)

Novel Psychoactive Substances (NPS): a Study on Persian Language Websites
por: BIGDELI, Imanollah, et al.
Publicado: (2013)

Hair analysis for New Psychoactive Substances (NPS): Still far from becoming the tool to study NPS spread in the community?
por: Florou, Dimitra, et al.
Publicado: (2021)

Suicidality and self-injury behaviours due to the use of Novel Psychoactive Substances (NPS)
por: Orsolini, L.
Publicado: (2023)

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review
por: Schifano, Fabrizio, et al.
Publicado: (2018)

Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) Phenomenon
por: Schifano, Fabrizio
Publicado: (2018)

Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2020)

Episodic Memories and Their Relevance for Psychoactive Drug Use and Addiction
por: Müller, Christian P.
Publicado: (2013)

Risk factors for the onset of dependence and chronic psychosis due to cannabis use: Survey of patients with cannabis‐related psychiatric disorders
por: Matsumoto, Toshihiko, et al.
Publicado: (2020)

Sales and Advertising Channels of New Psychoactive Substances (NPS): Internet, Social Networks, and Smartphone Apps
por: Miliano, Cristina, et al.
Publicado: (2018)

Corrigendum: Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2021)

Analyzing the Open/Deep Web to Better Understand the New/Novel Psychoactive Substances (NPS) Scenarios: Suggestions from CASSANDRA and NPS.Finder Research Projects
por: Schifano, Fabrizio
Publicado: (2020)

Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants
por: Miliano, Cristina, et al.
Publicado: (2016)

The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol
por: Khaled, Salma M., et al.
Publicado: (2016)

EDITORIAL: New Psychoactive Substances (NPS), a New Global Issue: Neuropharmacological, Chemical and Toxicological Aspects
por: Pichini, Simona, et al.
Publicado: (2017)

Rapid Detection and Quantification of Novel Psychoactive Substances (NPS) Using Raman Spectroscopy and Surface-Enhanced Raman Scattering
por: Muhamadali, Howbeer, et al.
Publicado: (2019)

Clinical Presentations and Predictors of In-Hospital Mortality in Illicit Drug Users in the New Psychoactive Substances (NPS) Endemic Era in Taiwan
por: Yeh, Hsin-Tzu, et al.
Publicado: (2022)

Study of effects of ifenprodil in patients with methamphetamine dependence: Protocol for an exploratory, randomized, double‐blind, placebo‐controlled trial
por: Kotajima‐Murakami, Hiroko, et al.
Publicado: (2019)

Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances
por: Di Trana, Annagiulia, et al.
Publicado: (2020)

AddictedChem: A Data-Driven Integrated Platform for New Psychoactive Substance Identification
por: Han, Mengying, et al.
Publicado: (2022)

Mechanistic Insights into the Stimulant Properties of Novel Psychoactive Substances (NPS) and Their Discrimination by the Dopamine Transporter—In Silico and In Vitro Exploration of Dissociative Diarylethylamines
por: Sahai, Michelle A., et al.
Publicado: (2018)

The Role of Dopamine in the Stimulant Characteristics of Novel Psychoactive Substances (NPS)—Neurobiological and Computational Assessment Using the Case of Desoxypipradrol (2-DPMP)
por: Loi, Barbara, et al.
Publicado: (2020)

Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project
por: Helander, Anders, et al.
Publicado: (2020)

Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications
por: Giorgetti, Arianna, et al.
Publicado: (2021)

Establishment of Neurotoxicity Assessment Using Microelectrode Array (MEA) with hiPSC-Derived Neurons and Evaluation of New Psychoactive Substances (NPS)
por: Kang, Kyu-ree, et al.
Publicado: (2022)

Analysis of Relationships between DAT1 Polymorphism Variants, Personality Dimensions, and Anxiety in New Psychoactive Substance (Designer Drug) (NPS) Users
por: Chmielowiec, Jolanta, et al.
Publicado: (2021)

Health and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries
por: Van Hout, Marie Claire, et al.
Publicado: (2017)

Corrigendum to ”HighResNPS.com: An Online Crowd-Sourced HR-MS Database for Suspect and Non-targeted Screening of New Psychoactive Substances”
por: Mardal, Marie, et al.
Publicado: (2019)

New psychoactive substances (NPS) in the Netherlands: occurrence in forensic drug samples, consumer drug samples and poisons center exposures between 2013 and 2017
por: Hondebrink, Laura, et al.
Publicado: (2020)

Does antipsychotic therapy prevent the development of chronic psychotic disorders in people addicted to ilegal psychoactive substances
por: Kasper, S. S., et al.
Publicado: (2023)

2012 Update in addiction medicine for the generalist
por: Rastegar, Darius A, et al.
Publicado: (2013)

Screening of new psychoactive substances (NPS) by gas-chromatography/time of flight mass spectrometry (GC/MS-TOF) and application to 63 cases of judicial seizure
por: Dei Cas, Michele, et al.
Publicado: (2019)

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022)

Psychoactive Comfort Products or Snacks: How Chinese Young Adults Perceive the Potentially Addictive Nature of E-Cigarettes
por: Song, Apei, et al.
Publicado: (2023)

Psychoactive drugs and driving
por: Parekh, Vanita
Publicado: (2019)

Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double‐blind, placebo‐controlled trial
por: Kotajima‐Murakami, Hiroko, et al.
Publicado: (2022)

Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts
por: Bonnet, Udo, et al.
Publicado: (2020)

Regulatory Policies for Alcohol, other Psychoactive Substances and Addictive Behaviours: The Role of Level of Use and Potency. A Systematic Review
por: Rehm, Jürgen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_86e3d4akokrl6602h8jg2r1qs9